Neovacs S.A.. (2/3/17). "Press Release: Neovacs Announces Independent Data and Safety Monitoring Board Supports Continuation of Phase IIb Clinical Trial for IFNa Kinoid in Lupus". Paris. |
2017-02-03 |
Genedata AG. (2/6/17). "Press Release: SLAS2017 – Genedata Announces BMG LABTECH, Creoptix and TTP Labtech as New Ready-to-Run Partners". Washington, DC. |
2017-02-06 |
Thermo Fisher Scientific Inc.. (2/6/17). "Press Release: Thermo Fisher Scientific Innovations Designed to Accelerate Research, Productivity and Discovery on Display at SLAS 2017". Washington, DC. |
2017-02-06 |
Analytik Jena AG. (2/6/17). "Press Release: One Million Tests a Week – Analytik Jena Optimizes the Process for Ultra High Throughput Screening". Jena & Washington, DC. |
2017-02-06 |
Lipotype GmbH. (2/6/17). "Press Release: Launch of BEAt-DKD. An Innovative Medicines Initiative (IMI) Project for Precision Medicine in Diabetic Kidney Disease with Lipotype as Project Partner". |
2017-02-06 |
Isogenica Ltd.. (2/6/17). "Press Release: Isogenica Announces New Licence Agreement with Maverick Therapeutics". Cambridge. |
2017-02-06 |
4SC AG. (2/6/17). "Press Release: 4SC AG to Present at the 19th Annual BIO CEO & Investor Conference 2017". Planegg-Martinsried. |
2017-02-06 |
Quotient Clinical. (2/6/17). "Press Release: Quotient Clinical Expands into USA through Acquisition of SeaView Research, the Specialist Clinical Pharmacology Business". Nottingham. |
2017-02-06 |
Bruker Corporation. (2/6/17). "Press Release: Bruker Introduces MALDI PharmaPulse 2.0 Solution at SLAS 2017 for 100x Faster Mass Spectrometry-Based, Label-Free Screening in Drug Discovery". |
2017-02-06 |
Uniqure N.V.. (2/6/17). "Press Release: Uniqure Announces Presentations at Upcoming February Conferences". Lexington, MA & Amsterdam. |
2017-02-06 |
Albany Molecular Research, Inc.. (2/7/17). "Press Release: AMRI Announces Strategic Alliance to Advance Mass Spectrometry Capabilities for Drug Discovery". Albany, NY. |
2017-02-07 |
GeNeuro S.A.. (2/7/17). "Press Release: GeNeuro Signs CRADA Agreement with NIH to Develop Novel Antibody Treatment for ALS". |
2017-02-07 |
OSE Immunotherapeutics S.A.. (2/7/17). "Press Release: OSE Immunotherapeutics to Present Corporate Overview at Upcoming BIO CEO & Investor Conference New York February 13-14, 2017". Nantes. |
2017-02-07 |
Atriva Therapeutics GmbH. (2/7/17). "Press Release: Atriva Reaches a Development Milestone and Receives an Additional Tranche of Running Seed Financing to Develop Its Influenza Therapeutic to Clinical Stage". Tübingen. |
2017-02-07 |
Atriva Therapeutics GmbH. (2/7/17). "Press Release: Atriva Receives Seed Financing to Develop Its Next Generation Influenza Therapeutic". Tübingen. |
2017-02-07 |
Numares AG. (2/7/167). "Press Release: Numares Initiates Worldwide Commercial Launch of insightLPTM-S50 to Provide New Insights in Lipoprotein Research". Regensburg. |
2017-02-07 |
Pharnext S.A.. (2/7/17). "Press Release: Pharnext to Present at 2017 BIO CEO & Investor Conference". Paris. |
2017-02-07 |
Minoryx Therapeutics S.L.. (2/8/17). "Press Release: Dr Claude Nicaise Joins Minoryx Therapeutics as Independent Board Member". Mataró, Barcelona. |
2017-02-08 |
Bayer AG. (2/8/17). "Press Release: Phase III COMPASS study with Bayer’s Rivaroxaban in Patients with Coronary or Peripheral Artery Disease Shows Overwhelming Efficacy and Meets Primary Endpoint Early []". Berlin. |
2017-02-08 |
Affimed N.V.. (2/8/17). "Press Release: Affimed to Present at the Leerink Partners 6th Annual Global Healthcare Conference". Heidelberg. |
2017-02-08 |
Prothena Corporation plc. (2/8/17). "Press Release: Prothena to Participate in the Leerink Partners 6th Annual Global Healthcare Conference". Dublin. |
2017-02-08 |
Medivir AB. (2/9/17). "Press Release: Christine Lind New CEO of Medivir AB Effective 1 April 2017". Stockholm. |
2017-02-09 |
Cevec Pharmaceuticals GmbH. (2/9/17). "Press Release: Cevec Licenses CAP Technologies for the Development and Commercialization of Vaccines against Zika Virus Infections". Cologne. |
2017-02-09 |
Nicox S.A.. (2/9/17). "Press Release: Nicox to Present at the 6th Annual Leerink Partners Global Healthcare Conference". Sophia Antipolis. |
2017-02-09 |
Analytik Jena AG. (2/9/17). "Press Release: Analytik Jena Wins New Product Award for Innovation in Nucleic Acid Extraction at SLAS 2017". Jena & Washington, DC. |
2017-02-09 |
Merus N.V.. (2/9/17). "Press Release: Merus to Present at the Leerink Partners 6th Annual Global Healthcare Conference". Utrecht. |
2017-02-09 |
MorphoSys AG. (2/10/17). "Press Release: MorphoSys to Present at Upcoming Conference". Planegg. |
2017-02-10 |
Noxxon Pharma N.V.. (2/10/17). "Press Release: Noxxon Pharma Announces Experienced Industry Cancer Clinician Dr. Jarl Ulf Jungnelius to Serve as Noxxon CMO". Berlin. |
2017-02-10 |
Immunicum AB. (2/13/17). "Press Release: Immunicum AB Appoints Karin Hoogendoorn as Head of CMC". Gothenburg. |
2017-02-13 |
Teva Pharmaceutical Industries Ltd.. (2/13/17). "Press Release: Teva Reports Full Year and Fourth Quarter 2016 Financial Results". Jerusalem. |
2017-02-13 |
Treos Bio, Ltd.. (2/13/17). "Press Release: Treos Bio Raises $8 Million in Private Investment Round". San Francisco, CA & London. |
2017-02-13 |
Eli Lilly and Company. (2/13/17). "Press Release: European Commission Approves Once-daily Olumiant Tablets for Treatment of Adults with Moderate-to-Severe Active Rheumatoid Arthritis". Indianapolis, IN. |
2017-02-13 |
Intellia Therapeutics, Inc.. (2/14/17). "Press Release: Joint Statement of Intellia Therapeutics & CRISPR Therapeutics – Position Regarding Human Germline Gene Editing". |
2017-02-14 |
Quotient Clinical. (2/14/17). "Press Release: Quotient Clinical Announces Second US Acquisition – QS Pharma". Nottingham. |
2017-02-14 |
Vifor Pharma AG. (2/14/17). "Press Release: Vifor Pharma and ChemoCentryx Announce Expansion of Avacopan Agreement for Rare Renal Diseases". |
2017-02-14 |
Johnson & Johnson. (2/14/17). "Press Release: Johnson & Johnson to Participate in Barclays Global Healthcare Conference". New Brunswick, NJ. |
2017-02-14 |
Prothena Corporation plc. (2/14/17). "Press Release: Prothena Reports Fourth Quarter and Full Year 2016 Financial Results, and Provides Financial Guidance and R&D Update". Dublin. |
2017-02-14 |
CRISPR Therapeutics AG. (2/15/17). "Press Release: CRISPR Therapeutics, Intellia Therapeutics, Caribou Biosciences and ERS Genomics Provide Update on CRISPR/Cas9 U.S. Patent Interference Proceedings and Grants of Corresponding Patents in the U.K.". Basel |
2017-02-15 |
Compugen Ltd.. (2/15/17). "Press Release: Compugen Reports Fourth Quarter and Calendar Year 2016 Results". Holon. |
2017-02-15 |
Boehringer Ingelheim. (2/15/17). "Press Release: Boehringer Ingelheim and Weill Cornell Medicine Announce New Collaboration to Discover Next Generation COPD Treatments". Ingelheim. |
2017-02-15 |
Euronext N.V.. (2/15/17). "Press Release: Inventiva Lists on Euronext Paris. €48 Million Raised, Market Capitalisation €133 Million". Paris. |
2017-02-15 |
BioInvent International AB. (2/15/17). "Press Release: BioInvent Financial Statement 1 January – 31 December 2016". |
2017-02-15 |
MorphoSys AG. (2/15/17). "Press Release: District Court Grants MorphoSys's Request to Add Second Patent in Lawsuit with Janssen Biotech and Genmab". Planegg. |
2017-02-15 |
Alcobra Ltd.. (2/15/17). "Press Release: Alcobra Announces Fourth-quarter and Full-year 2016 Financial Results and Provides Corporate Update". Tel Aviv. |
2017-02-15 |
Bayer AG. (2/15/17). "Press Release: Bayer to Showcase Xofigo Prostate Cancer Data at ASCO GU 2017 [Not intended for U.S. and UK Media]". Berlin. |
2017-02-15 |
Boehringer Ingelheim. (2/16/17). "Press Release: US FDA Expands Approval of Tiotropium Respimat for Maintenance Treatment of Asthma in Children". Ingelheim. |
2017-02-16 |
Mologen AG. (2/16/17). "Press Release: New Positive Data on Lefitolimod in HIV". |
2017-02-16 |
PerkinElmer, Inc.. (2/16/17). "Press Release: PerkinElmer to Present at Barclays Capital Global Healthcare Conference". Waltham, MA. |
2017-02-16 |
Immunicum AB. (2/17/17). "Press Release: Year-end Report 2016 (July 2016 – December 2016)". Gothenburg. |
2017-02-17 |
Medivir AB. (2/17/17). "Press Release: Financial Statement, January – December 2016". |
2017-02-17 |
Cerenis Therapeutics S.A.. (2/17/16). "Press Release: 2016 Annual Results. Solid Cash Position of €24.7 million and Finalization of CARAT Phase 2 Clinical Study". Toulouse & Ann Arbor, MI. |
2017-02-17 |
University of Warwick. (2/17/17). "Press Release: Molecular Phenomenon Discovered by Advanced NMR Facility". |
2017-02-17 |
Mologen AG. (2/17/17). "Press Release: Mologen to Present at ASCO-SITC Clinical Immuno-Oncology Symposium 2017". |
2017-02-17 |
AstraZeneca plc. (2/20/17). "Press Release: AstraZeneca Enters Agreement with TerSera Therapeutics for Zoladex in the US and Canada". |
2017-02-20 |
Analytik Jena AG. (2/20/17). "Press Release: Analytik Jena Presents Innovative Applications for Its Elite Product Range of ICP-MS and ICP-OES Instruments at EWCPS 2017". Jena & Sankt Anton. |
2017-02-20 |
CellGenix GmbH. (2/21/17). "Press Release: CellGenix Headquarters Expands to Meet the Increasing Demands for GMP Cell Culture Reagents". Freiburg. |
2017-02-21 |
Lysogene S.A.. (2/21/17). "Press Release: Lysogene Receives Orphan Drug Designation from EMA for LYS-GM101 for Treatment of GM1 Gangliosidosis". Paris & Cambridge, MA. |
2017-02-21 |
Biophytis S.A.. (2/21/17). "Press Release: Biophytis Relocates to Pierre and Marie Curie University (UPMC) Campus and Solidifies Creation of Leading Translational Platform for Age-related Disease". Paris. |
2017-02-21 |
TxCell S.A.. (2/22/17). "Press Release: TxCell Successfully Completes a €11 Million Capital Increase [Not for release directly or indirectly in the United States of America, Canada, Australia or Japan]". Valbonne. |
2017-02-22 |
Bayer AG. (2/22/17). "Press Release: Fiscal 2016. Another Record Year for Bayer – Good Progress with the Acquisition of Monsanto". Leverkusen. |
2017-02-22 |
Bayer AG. (2/22/17). "Press Release: Financial News Conference. Address by Werner Baumann –Chairman of the Board of Management". Leverkusen. |
2017-02-22 |
Bayer AG. (2/22/17). "Press Release: Financial News Conference. Address by Johannes Dietsch –Member of the Board of Management". Leverkusen. |
2017-02-22 |
EFPIA. (2/22/17). "Press Release: Nathalie Moll Announced as New EFPIA Director General, Starting in April 2017". |
2017-02-22 |
ChemAxon Kft.. (2/22/17). "Press Release: IDBS and ChemAxon Partnership Extends to Harness Leading Biomolecule Handling Technology". London, Budapest & Boston, MA. |
2017-02-22 |
Minoryx Therapeutics S.L.. (2/22/17). "Press Release: Minoryx Therapeutics Receives Orphan Drug Designation from the US FDA for Its Lead Candidate MIN-102". Mataró, Barcelona. |
2017-02-22 |
BaselArea.swiss. (2/22/17). "Press Release: Startup Accelerator BaseLaunch Aims to Attract Promising Healthcare Ventures to Basel, Europe’s Leading Life Sciences Hub". Basel. |
2017-02-22 |
Valneva S.E.. (2/23/17). "Press Release: Valneva Reports Strong Q4 and FY 2016 Business Performance, Expects Further Growth in Sales and EBITDA, R&D Progress in 2017". Lyon. |
2017-02-23 |
Ipsen S.A.. (2/23/17). "Press Release: Ipsen Delivers Strong 2016 Results and Expects Further Sales Growth and Margin Enhancement for 2017". Paris. |
2017-02-23 |
Galapagos N.V.. (2/23/17). "Press Release: Galapagos Reports Strong Financial Results and Newsflow-rich Pipeline". Mechelen. |
2017-02-23 |
Galapagos N.V.. (2/23/17). "Press Release: Galapagos Doses First Healthy Volunteer with CF Combo GLPG2222 and GLPG2451". Mechelen. |
2017-02-23 |
Sartorius AG. (2/23/17). "Press Release: Sartorius Reviews Fiscal 2016". Göttingen. |
2017-02-23 |
Novartis AG. (2/23/17). "Press Release: Novartis Drug Zykadia Receives FDA Priority Review for First-line Use in Patients with ALK+ Metastatic NSCLC". Basel. |
2017-02-23 |
Johnson & Johnson. (2/24/17). "Press Release: Darzalex (daratumumab) Receives Positive CHMP Opinion for the Treatment of Multiple Myeloma in Patients who have Received At Least One Prior Therapy". Beerse. |
2017-02-24 |
AstraZeneca plc. (2/24/17). "Press Release: ZS-9 (sodium zirconium cyclosilicate) Receives Positive CHMP Opinion for the Treatment of Hyperkalaemia". |
2017-02-24 |
Napp Pharmaceuticals Ltd.. (2/24/17). "Press Release: Napp Launches Truxima (rituximab), the First Biosimilar Monoclonal Antibody for the Treatment of Cancer, in the UK". Cambridge. |
2017-02-24 |
bioMérieux S.A.. (2/24/17). "Press Release: bioMérieux’s VIDAS B•R•A•H•M•S PCT Becomes the First FDA-cleared Procalcitonin Assay as an Aid for Antibiotic Stewardship in Respiratory Infections and Sepsis". |
2017-02-24 |
PureTech Health plc. (2/24/17). "Press Release: PureTech Health to Present at the Cowen and Company 37th Annual Health Care Conference". Boston, MA. |
2017-02-24 |
Merus N.V.. (2/27/17). "Press Release: Merus to Present at the Cowen & Co. 37th Annual Health Care Conference". Utrecht. |
2017-02-27 |
Oryzon Genomics S.A.. (2/27/17). "Press Release: Oryzon Presented New Preclinical Data of ORY-2001 Therapeutic Activity in Multiple Sclerosis at ACTRIMS-2017". Barcelona & Cambridge, MA. |
2017-02-27 |
MolMed S.p.A.. (2/27/17). "Press Release: MolMed and Rocket Pharma Establish a Collaboration Agreement in the Field of Gene Therapy for the Treatment of Fanconi Anemia". Milan. |
2017-02-27 |
Congenica Ltd.. (2/27/17). "Press Release: Congenica Raises £8M ($10M) in Series B Financing Round to Drive International Expansion of Its Genome Analysis Business". Cambridge. |
2017-02-27 |
Affimed N.V.. (2/28/17). "Press Release: Affimed to Present at the Cowen and Company 37th Annual Health Care Conference". Heidelberg. |
2017-02-28 |
Novartis AG. (2/28/17). "Press Release: Novartis Shareholders Approve All Resolutions Proposed by Board of Directors at the Annual General Meeting". Basel. |
2017-02-28 |
AstraZeneca plc. (2/28/17). "Press Release: FDA Approves Once-daily Qtern (dapagliflozin and saxagliptin) Tablets for Adults with Type-2 Diabetes". |
2017-02-28 |
Eurofins Scientific. (2/28/17). "Press Release: Eurofins Achieves Its Recently-upgraded 2016 Objectives and Delivers Its Best Year Ever on Sustained Growth Momentum". |
2017-02-28 |
Affimed N.V.. (3/1/17). "Press Release: Affimed to Present Data on Immune Cell Engagers at the AACR Annual Meeting 2017". Heidelberg. |
2017-03-01 |
Cerenis Therapeutics S.A.. (3/1/17). "Press Release: Cerenis Therapeutics Announces Top Line Results of CARAT Phase II Study. No Statistical Difference Observed between CER-001 and Placebo". Toulouse & Ann Arbor, MI. |
2017-03-01 |
Werum IT Solutions AG. (3/1/17). "Press Release: Werum America Reinforces Key Account Relations with Experienced Pharma Manufacturing Specialist". Lüneburg & Parsippany, NJ. |
2017-03-01 |
Science 37 Inc.. (3/1/17). "Press Release: Science 37 and Sanofi Introduce a New Partnership". Basel. |
2017-03-01 |
Nicox S.A.. (3/1/17). "Press Release: Nicox to Participate at Two Upcoming Investor Conferences". Sophia Antipolis. |
2017-03-01 |
Uniqure N.V.. (3/1/17). "Press Release: Uniqure Announces Presentations at Upcoming March Conferences". Lexington, MA & Amsterdam. |
2017-03-01 |
Prothena Corporation plc. (3/2/17). "Press Release: Prothena Announces Public Offering of Ordinary Shares". Dublin. |
2017-03-02 |
Adaptimmune Therapeutics plc. (3/2/17). "Press Release: Adaptimmune to Present at the Cowen and Company 37th Annual Health Care Conference". Philadeliphia, PA & Oxford. |
2017-03-02 |
Boehringer Ingelheim. (3/2/17). "Press Release: Boehringer Ingelheim Expands Collaboration with Vanderbilt University to Tackle Some of the Most Difficult-to-treat Cancers". Ingelheim. |
2017-03-02 |
Agilent Technologies Inc.. (3/2/17). "Press Release: Agilent Technologies Introduces Postnatal Assay for Detection of Genetic Anomalies. GenetiSure Dx Postnatal Assay Can Help Move Inquiries from Cause to Care Faster". Santa Clara, CA. |
2017-03-02 |
Bicycle Therapeutics Ltd.. (3/2/17). "Press Release: Bicycle Therapeutics to Present at Cowen and Company 37th Annual Health Care Conference". Cambridge, MA & Cambridge. |
2017-03-02 |
PureTech Health plc. (3/2/17). "Press Release: PureTech Health Appoints Bharatt Chowrira, Ph.D., J.D., as President and Chief of Business and Strategy". Boston, MA. |
2017-03-02 |
CRISPR Therapeutics AG. (3/2/17). "Press Release: CRISPR Therapeutics to Present at the Annual Barclays Global Healthcare Conference". Basel & Cambridge, MA. |
2017-03-02 |
Newron Pharmaceuticals S.p.A.. (3/2/17). "Press Release: Newron Announces 2016 Financial Results and Provides Outlook for 2017". Milan. |
2017-03-02 |
bioMérieux S.A.. (3/3/17). "Press Release: 2016 Financial Results". |
2017-03-03 |